Biocatalysis for the asymmetric synthesis of Active Pharmaceutical Ingredients (APIs): this time is for real.
Gonzalo de GonzaloAndrés R AlcántaraPablo Domínguez de MaríaJosé María Sánchez-MonteroPublished in: Expert opinion on drug discovery (2022)
) and with excellent selectivity, making them inspiring strategies for present and future industrial applications. The combination of powerful molecular biology techniques with the needs of the pharmaceutical industry can be aligned, creating promising platforms for synthesis under more sustainable conditions.